Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.
about
Bag6 complex contains a minimal tail-anchor-targeting module and a mock BAG domainCrystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding siteThe interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicityCritical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic StressEvasion from NK cell-mediated immune responses by HIV-1Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategiesThe role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetesHLA-dependent tumour development: a role for tumour associate macrophages?Coevolution of MHC genes (LMP/TAP/class Ia, NKT-class Ib, NKp30-B7H6): lessons from cold-blooded vertebratesModulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutininElucidating the mechanisms of influenza virus recognition by Ncr1Overexpression of peroxisomal testis-specific 1 protein induces germ cell apoptosis and leads to infertility in male miceBat3 deficiency accelerates the degradation of Hsp70-2/HspA2 during spermatogenesis.BAT3 regulates Mycobacterium tuberculosis protein ESAT-6-mediated apoptosis of macrophagesDendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer functionKilling of avian and Swine influenza virus by natural killer cellsStructure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansA soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cellsNovel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathwayA novel BAT3 sequence generated by alternative RNA splicing of exon 11B displays cell type-specific expression and impacts on subcellular localization.Increase of IFN-γ and TNF-α production in CD107a + NK-92 cells co-cultured with cervical cancer cell lines pre-treated with the HO-1 inhibitor.Oncogenic stress sensed by the immune system: role of natural killer cell receptorsCoordinated regulation of NK receptor expression in the maturing human immune system.Recognition of tumors by the innate immune system and natural killer cells.Evasion of natural killer cells by influenza virus.Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attackThe structural basis of ligand recognition by natural killer cell receptors.Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer CellsB7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape.Natural killer cells: role in local tumor growth and metastasisA novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen.Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.Human herpesviridae methods of natural killer cell evasion
P2860
Q24311324-501FF162-AC2F-4BF8-B478-AEE4FD976CDBQ24615889-2152234C-10A4-403F-9484-F9BE82BA2693Q24651041-435E1F79-5B92-43CF-AAF2-B6FEA4929B97Q26781260-4BECE4B2-3663-462D-88D1-1DAA4F9C9203Q26864489-3AB052E9-11DC-4A24-B86A-B56B540B5FCFQ26996660-5CE45794-AB63-44AF-8587-514D7997E4BBQ27003384-51AB399B-D709-4538-87F4-6D243BA7863BQ27022124-00057139-A9BD-4E1E-B1D9-6246CF12B51BQ28081315-D8BB76BF-45F6-4223-89A0-88774F27BA06Q28476707-94734621-F946-4AEC-B4FE-E9F9DCB9E1B0Q28586365-15766EBB-4944-45F0-BFF4-26E87042D575Q28587046-946C4BDF-84BA-4E31-9189-6D8F455D51E9Q28592901-E4F13F7F-7D10-41EE-80A0-5E94C5C64ACEQ28727070-88E92321-113C-49EE-AADA-613E53D49087Q28854563-82E59DAB-5E50-47FF-8C30-8B2A7C7877FAQ30385326-EFC97C78-3CB2-4CDB-962B-79825C87B8FBQ30668576-5A43E892-9E5F-412E-B366-32D17669EA41Q30975364-B6651FA6-6902-4882-9EA7-05D66EB249F0Q33292180-0A394790-A9B8-4415-A30F-D0BA8E5DAE8AQ33292224-250F1520-6C75-4BC4-B555-1EE63F110CD1Q33292470-0B37C0C3-C0F4-490E-8D82-427A4289955CQ33292532-219A16CB-52B8-4D4B-8E19-577E171DA7ACQ33672480-F0ED0027-8639-4B8D-88E4-BD9085FCDB86Q33914138-D8D59315-40A6-46F9-A18B-2EE5C4D05749Q34256996-F44E20A0-0DA0-4B1D-A133-618922FD14D5Q34308800-3B0058E0-D92F-4566-8F47-699ABE5E989CQ34473267-B5E3BCFC-AD21-4916-98F2-B5217C2A32A9Q34476273-D0E7F012-48B7-4F76-A139-6F99E2C3F64BQ34496462-2F1FC8A8-2B48-4D5F-8790-2FAC914287C5Q34510128-51737F39-4816-4254-903F-3DBC03613D51Q34580297-EDA37D97-F411-4E71-97FE-0C5AE83C299BQ35001148-22DB8DF7-B48B-4560-9F3A-BC704497783CQ35083496-705A9A46-6E46-417D-BC16-6527E9A7F9BBQ35131244-3EB5D7F9-19C9-4F9C-92DD-C661791D5B69Q35687743-B590F86F-C86D-47CE-BFA7-C02E8DEFB29BQ35798978-C3C0E230-6D90-405C-89AC-85E3160D153BQ35905953-BC2B8CC2-A26E-4A6F-9ACC-46B909A30988Q36057472-34C4FC01-0FB4-4429-85CC-E87FAA2806ACQ36094697-DE765A32-DE30-40A9-9D44-C81616902849Q36102137-ABC56E61-5630-4FAE-987B-3F064E07B4ED
P2860
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Human leukocyte antigen-B-asso ...... eptor on natural killer cells.
@ast
Human leukocyte antigen-B-asso ...... eptor on natural killer cells.
@en
type
label
Human leukocyte antigen-B-asso ...... eptor on natural killer cells.
@ast
Human leukocyte antigen-B-asso ...... eptor on natural killer cells.
@en
prefLabel
Human leukocyte antigen-B-asso ...... eptor on natural killer cells.
@ast
Human leukocyte antigen-B-asso ...... eptor on natural killer cells.
@en
P2093
P1433
P1476
Human leukocyte antigen-B-asso ...... eptor on natural killer cells.
@en
P2093
Achim Rothe
Andreas Engert
Bastian von Tresckow
Boris Böll
Hinrich P Hansen
Katrin S Reiners
Peter Borchmann
Peter J McKinnon
Stephanie Sasse
Venkateswara Rao Simhadri
P304
P356
10.1016/J.IMMUNI.2007.10.010
P407
P577
2007-12-06T00:00:00Z